
West Pharmaceutical reported Q2 earnings and revenue beat, higher 2026 guidance, and continued strength in GLP-1 and HVP products.
You can purchase shares of West Pharmaceutical Servs (NYSE:WST) through any online brokerage.
Other companies in West Pharmaceutical Servs’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
West Pharmaceutical Servs has a consensus price target of $424.50.
The stock price for West Pharmaceutical Servs (NYSE: WST) is $391 last updated November 5, 2026 at 4:30 PM EST.
There are no upcoming dividends for West Pharmaceutical Servs.
West Pharmaceutical Servs does not have any upcoming earnings scheduled.
There is no upcoming split for West Pharmaceutical Servs.
West Pharmaceutical Servs is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers),...